FDA Bans Certain Imports From Indian Drugmaker Wockhardt

Law360, New York (May 23, 2013, 4:04 PM EDT) -- The U.S. Food and Drug Administration on Wednesday blocked certain imports from India-based drugmaker Wockhardt Ltd. after inspections allegedly turned up violations of good manufacturing practices.

The so-called import alert affects medications that Wockhardt produces at a plant in the Indian city of Aurangabad, which sits about 200 miles east of Mumbai. Company executives predicted it will take months to have the ban lifted and that, in a worst-case scenario, they stand to lose $100 million in revenue, according to published reports.

Wockhardt has 14 manufacturing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.